Wockhardt Reports Strong Turnaround with Q1 FY27 Profit of ₹107 Crore

Wockhardt Ltd has announced a significant financial turnaround for the first quarter of FY27, reporting a consolidated net profit of ₹107 crore. This marks a substantial improvement from the net loss of ₹108 crore recorded in the same quarter last year. The company's consolidated revenue from operations reached ₹929 crore for the quarter ended June 30, 2026.

Reader Takeaway: Strong profit turnaround driven by revenue growth, but reliance on subsidiary financials needs monitoring.

What just happened

Wockhardt has achieved a consolidated net profit of ₹107 crore in Q1 FY27, a reversal from a ₹108 crore loss in Q1 FY26. Consolidated revenue grew to ₹929 crore from ₹738 crore year-on-year. The company operates solely within the pharmaceutical segment.

Why this matters

This turnaround is crucial for investor confidence, demonstrating Wockhardt's ability to return to profitability. The growth in revenue indicates strengthening market performance for its pharmaceutical products.

The backstory

Wockhardt is a pharmaceutical company. The previous year's performance showed a net loss, making this quarter's profit a key indicator of recovery and strategic execution.

What changes now

The positive financial results could signal a new phase of growth for Wockhardt, potentially impacting its stock performance. Investors will be keen to see if this trend continues.

Risks to watch

Auditors noted reliance on other auditors for 5 subsidiaries and management certification for 18 subsidiaries, which could present transparency challenges. The financial information for these subsidiaries contributed ₹777 crore in revenue with a net loss of ₹2 crore from the 5 entities, and ₹46 crore revenue with a ₹10 crore profit from the 18 entities.

Peer comparison

(No specific peer comparison data available in the filing.)

Context metrics (time-bound)

Consolidated Revenue Q1 FY27: ₹929 crore (vs ₹738 crore in Q1 FY26)
Consolidated Net Profit Q1 FY27: ₹107 crore (vs ₹108 crore loss in Q1 FY26)
Basic EPS Q1 FY27: ₹6.55 (vs ₹5.53 loss in Q1 FY26)
Standalone Revenue Q1 FY27: ₹561 crore
Standalone Net Profit Q1 FY27: ₹107 crore

What to track next

Investors should closely monitor the company's future quarterly results, particularly the consolidated performance and the evolving reliance on subsidiary financial certifications.